Ilse Dieussaert

2.4k total citations · 1 hit paper
38 papers, 1.1k citations indexed

About

Ilse Dieussaert is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Ilse Dieussaert has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 11 papers in Microbiology and 9 papers in Infectious Diseases. Recurrent topics in Ilse Dieussaert's work include Respiratory viral infections research (19 papers), Influenza Virus Research Studies (16 papers) and Pneumonia and Respiratory Infections (14 papers). Ilse Dieussaert is often cited by papers focused on Respiratory viral infections research (19 papers), Influenza Virus Research Studies (16 papers) and Pneumonia and Respiratory Infections (14 papers). Ilse Dieussaert collaborates with scholars based in Belgium, United States and Germany. Ilse Dieussaert's co-authors include Lode Schuerman, Patricia Lommel, Jacek Wysocki, Timo Vesikari, Aino Karvonen, Bertrand Chevallier, Hanna Czajka, Juan Carlos Tejedor Torres, Nancy Bermal and Leszek Szenborn and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Clinical Infectious Diseases.

In The Last Decade

Ilse Dieussaert

37 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

RSV Prefusion F Protein–Based Maternal Vaccine — Preterm Birth and Other Outcomes

2024 62 citations Ilse Dieussaert, Joon Hyung Kim et al. profile →

Peers

Countries citing papers authored by Ilse Dieussaert

Since Specialization

Citations

This map shows the geographic impact of Ilse Dieussaert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilse Dieussaert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilse Dieussaert more than expected).

Fields of papers citing papers by Ilse Dieussaert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilse Dieussaert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilse Dieussaert. The network helps show where Ilse Dieussaert may publish in the future.

Co-authorship network of co-authors of Ilse Dieussaert

This figure shows the co-authorship network connecting the top 25 collaborators of Ilse Dieussaert. A scholar is included among the top collaborators of Ilse Dieussaert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilse Dieussaert. Ilse Dieussaert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Establishing Correlates of Maternal-Fetal Cytomegalovirus Transmission—One Step Closer Through Predictive Modeling 2024 ·The Journal of Infectious Diseases ·(unknown), (unknown), Hannah Alsdurf, Vanesa Bol, (unknown), Nathalie De Schrevel, (unknown), Roland Devlieger, Ilse Dieussaert, Catherine Donner, Michel Janssens, (unknown), Anil A. Panackal, Cláudia Seidl, Robert A. Berg, Robert Paris	1
2	Incidence of Cytomegalovirus Primary and Secondary Infection in Adolescent Girls: Results From a Prospective Study 2023 ·The Journal of Infectious Diseases ·Robert Paris, Dan Apter, Suresh B. Boppana, (unknown), Nathalie De Schrevel, (unknown), (unknown), Adrienne Guignard, Anil A. Panackal, François Roman, Jing Yu, Elsa Yunes, Ilse Dieussaert	4
3	Safety and Immunogenicity of Respiratory Syncytial Virus Prefusion Maternal Vaccine Coadministered With Diphtheria-Tetanus-Pertussis Vaccine: A Phase 2 Study 2023 ·The Journal of Infectious Diseases ·(unknown), Murdo Ferguson, Isabel Leroux‐Roels, (unknown), (unknown), Nancy Hua, Peter van Steen, (unknown), Ilse Dieussaert, Joon Hyung Kim	10
4	First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector–Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults 2019 ·Clinical Infectious Diseases ·Paola Cicconi, Claire Jones, (unknown), Laura Silva-Reyes, Paul Klenerman, Catherine de Lara, Claire Hutchings, Philippe Moris, Michel Janssens, Laurence Fissette, (unknown), Amanda Leach, (unknown), Ilse Dieussaert, Matthew D. Snape	43
5	First-in-human randomized study to assess the safety and immunogenicity of an investigational respiratory syncytial virus (RSV) vaccine based on ChAd155 viral vector expressing RSV viral proteins F, N and M2-1 in healthy adults. 2019 ·Clinical Infectious Diseases ·Paola Cicconi, Claerwen M. Jones, (unknown), Laura Silva-Reyes, Paul Klenerman, Catherine de Lara, Claire Hutchings, Philippe Moris, Michel Janssens, Laurence Fissette, (unknown), Amanda Leach, André Lopez, Ilse Dieussaert, (unknown)	4
6	A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant 2016 ·The Journal of Infectious Diseases ·Joanne M. Langley, Naresh Aggarwal, (unknown), Scott A. Halperin, Shelly McNeil, Laurence Fissette, Walthère Dewé, Maarten Leyssen, Jean‐François Toussaint, Ilse Dieussaert	53
7	Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine 2015 ·The Pediatric Infectious Disease Journal ·Timo Vesikari, Jan Hendrik Richardus, Johan Berglund, Tiina Korhonen, Carl‐Erik Flodmark, Ann Lindstrand, Sven‐Arne Silfverdal, (unknown), Adrian Caplanusi, Ilse Dieussaert, Sumita Roy–Ghanta, David W. Vaughn	5
8	Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents 2011 ·Vaccine ·José García-Sicilia, Paul Gillard, Alfonso Carmona, Juan Carlos Tejedor Torres, Javier Arı́stegui, José Merino, Ulrich Behre, Adrian Caplanusi, (unknown), Ilse Dieussaert	27
9	Immunogenicity of 10-Valent Pneumococcal Nontypeable Haemophilus Influenzae Protein D Conjugate Vaccine When Administered as Catch-up Vaccination to Children 7 Months to 5 Years of Age 2011 ·The Pediatric Infectious Disease Journal ·Timo Vesikari, Aino Karvonen, Tiina Korhonen, (unknown), Karita Sadeharju, (unknown), Ilse Dieussaert, Lode Schuerman	13
10	Safety and Immunogenicity of a Booster Dose of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine Coadministered With Measles-Mumps-Rubella-Varicella Vaccine in Children Aged 12 to 16 Months 2010 ·The Pediatric Infectious Disease Journal ·Timo Vesikari, Aino Karvonen, (unknown), Tiina Korhonen, Patricia Lommel, Paul Willems, Ilse Dieussaert, Lode Schuerman	31
11	SAFETY AND IMMUNOGENICITY OF A BOOSTER DOSE OF THE 10-VALENT PNEUMOCOCCAL NONTYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN D CONJUGATE VACCINE COADMINISTERED WITH DTPW-HBV/HIB AND POLIOVIRUS VACCINES 2010 ·The Pediatric Infectious Disease Journal ·Nancy Bermal, Leszek Szenborn, Edison Alberto, (unknown), (unknown), Ewa Majda-Stanisławska, Salvacion Gatchalian, (unknown), Ilse Dieussaert, Lode Schuerman	26
12	Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6–35 months 2010 ·Vaccine ·Alfonso Carmona, Félix Omeñaca, Juan Carlos Tejedor Torres, José Merino, (unknown), Ilse Dieussaert, Paul Gillard, Javier Arı́stegui	76
13	The 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Coadministered With DTPw-HBV/Hib and Poliovirus Vaccines: Assessment of Immunogenicity 2009 ·The Pediatric Infectious Disease Journal ·Nancy Bermal, Leszek Szenborn, (unknown), Edison Alberto, Patricia Lommel, Salvacion Gatchalian, Ilse Dieussaert, Lode Schuerman	75
14	Immunogenicity of Routinely Used Childhood Vaccines When Coadministered With the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) 2009 ·The Pediatric Infectious Disease Journal ·Markus Knuf, Leszek Szenborn, (unknown), C. Petit, Nancy Bermal, (unknown), Ilse Dieussaert, Lode Schuerman	76
15	Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) When Coadministered With Different Neisseria meningitidis Serogroup C Conjugate Vaccines 2009 ·The Pediatric Infectious Disease Journal ·Jacek Wysocki, Juan Carlos Tejedor Torres, (unknown), Ryszard Konior, José García-Sicilia, Markus Knuf, (unknown), Ilse Dieussaert, Lode Schuerman	80
16	Antibody Responses Following Administration of 10-Valent Pneumococcal Non-Typeable Haemophilus influenzas Protein D-Conjugate Vaccine (PHiD-CV) in Filipino Infants 2008 ·International Journal of Infectious Diseases ·Nancy Bermal, Edison Alberto, (unknown), (unknown), (unknown), Salvacion Gatchalian, Ilse Dieussaert, Lode Schuerman	1
17	Accelerated Vaccination Schedules Provide Protection against Hepatitis A and B in Last-minute Travelers 2006 ·Journal of Travel Medicine ·Hans Dieter Nothdurft, Jane N. Zuckerman, M. Stoffel, Ilse Dieussaert, Pierre Van Damme	19
18	Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1–11-year-old children 2005 ·Vaccine ·Don Roberton, Helen Marshall, (unknown), Étienne Sokal, Javier Díez‐Domingo, (unknown), Lars Rombo, (unknown), (unknown), (unknown), (unknown), (unknown), Diego Van Esso, Ilse Dieussaert, M. Stoffel	11
19	Immunogenicity of Twinrix™ in older adults: a critical analysis 2003 ·Expert Review of Vaccines ·M. Stoffel, Marc Lievens, Ilse Dieussaert, (unknown), Francis André	26
20	Reactogenicity and Immunogenicity of a Lyme Disease Vaccine in Children 2–5 Years Old 2000 ·Clinical Infectious Diseases ·Jiřı́ Beran, Norbert De Clercq, Ilse Dieussaert, Christian Van Hoecke	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact